Literature DB >> 7058469

Observations on the bite of the Mozambique spitting cobra (Naja mossambica mossambica).

C R Tilbury.   

Abstract

Experience in the treatment of bites by the Mozambique spitting cobra. Naja mossambica mossambica Peters, is described, and it is shown that the predominant effect of the venom is cytotoxic. The gross pathology of the bite is presented. A large percentage of the bites (94%) occurred inside human dwellings, and of these, 81% occurred while the victims were asleep. The efficacy of the SAIMR's polyvalent antivenom was tested, and the evidence suggests that its effectiveness is indirectly proportional to the time which has elapsed between the bite and the administration of the antivenom. A comparison of the data with those presented by Warrell et al. in respect of bites by Naja nigricollis in Nigeria, shows that the clinical effects of bites by N. mossambica and N. nigricollis are closely related.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058469

Source DB:  PubMed          Journal:  S Afr Med J


  11 in total

1.  Experimental studies on the spitting cobra ophthalmia (Naja nigricollis).

Authors:  J Grüntzig; W Lenz; B Berkemeier; D Mebs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

2.  Severe neurotoxic envenoming by the Malayan krait Bungarus candidus (Linnaeus): response to antivenom and anticholinesterase.

Authors:  D A Warrell; S Looareesuwan; N J White; R D Theakston; M J Warrell; W Kosakarn; H A Reid
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-26

3.  Anticoagulant Activity of Naja nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib.

Authors:  Taline D Kazandjian; Arif Arrahman; Kristina B M Still; Govert W Somsen; Freek J Vonk; Nicholas R Casewell; Mark C Wilkinson; Jeroen Kool
Journal:  Toxins (Basel)       Date:  2021-04-23       Impact factor: 4.546

4.  First Look at the Venom of Naja ashei.

Authors:  Konrad Kamil Hus; Justyna Buczkowicz; Vladimír Petrilla; Monika Petrillová; Andrzej Łyskowski; Jaroslav Legáth; Aleksandra Bocian
Journal:  Molecules       Date:  2018-03-08       Impact factor: 4.411

5.  Protein Identification of Venoms of the African Spitting Cobras, Naja mossambica and Naja nigricincta nigricincta.

Authors:  Ottilie Katali; Loide Shipingana; Peter Nyarangó; Mirva Pääkkönen; Erastus Haindongo; Timothy Rennie; Peter James; John Eriksson; Christian John Hunter
Journal:  Toxins (Basel)       Date:  2020-08-14       Impact factor: 4.546

6.  Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib).

Authors:  Mátyás A Bittenbinder; Christina N Zdenek; Bianca Op den Brouw; Nicholas J Youngman; James S Dobson; Arno Naude; Freek J Vonk; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2018-12-04       Impact factor: 4.546

7.  Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality.

Authors:  Mitchel Otieno Okumu; James Mucunu Mbaria; Joseph Kangangi Gikunju; Paul Gichohi Mbuthia; Vincent Odongo Madadi; Francis Okumu Ochola; Kenneth Narotso Maloba; Joseph Gichuki Nderitu
Journal:  Toxicon X       Date:  2022-04-27

8.  Influential Factors of Local Tissue Necrosis after Taiwan Cobra Bites: A Secondary Analysis of the Clinical Significance of Venom Detection in Patients of Cobra Snakebites.

Authors:  Chih-Chuan Lin; Chung-Hsien Chaou; Shi-Ying Gao
Journal:  Toxins (Basel)       Date:  2021-05-07       Impact factor: 4.546

9.  Wound Infections from Taiwan Cobra (Naja atra) Bites: Determining Bacteriology, Antibiotic Susceptibility, and the Use of Antibiotics-A Cobra BITE Study.

Authors:  Heng Yeh; Shi-Ying Gao; Chih-Chuan Lin
Journal:  Toxins (Basel)       Date:  2021-03-02       Impact factor: 4.546

10.  The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms.

Authors:  Abhinandan Chowdhury; Matthew R Lewin; Christina N Zdenek; Rebecca Carter; Bryan G Fry
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.